What stuff is this! A historical perspective on fibrinoid necrosis

Journal of Pathology

Volumn 191, Issue 3, 2000, Pages 235-238

  Bajema, Ingeborg M ^a   Bruijn, Jan A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ANCA; Fibrinoid necrosis; Systemic vasculitis

Indexed keywords

FIBRIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTERY WALL; AUTOIMMUNITY; CELL DEATH; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVIEW; STAINING; SYSTEMIC VASCULITIS; TISSUE NECROSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTERIES; AUTOIMMUNITY; FIBRIN; HUMANS; KIDNEY; NECROSIS; VASCULITIS;

EID: 0033936054     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(0000)9999:99993.0.CO;2-I     Document Type: Review

References (44)

1. Oxford English Dictionary, vol V. Clarendon Press: Oxford, 1989.
2. Neumann E. Die Picrocarminfärbung und ihre Anwendung auf die Entzündungslehre. Arch Mikrosk Anat 1880; 18: 130-150.
3. Kussmaul A, Maier R. Ueber eine bisher nicht beschriebene eigenthümliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med 1866; 1: 323-343.
4. Polyarteritis Nodosa: Commemorative Translation on the 130-Year Anniversary of the Original Article by Adolf Kussmaul and Rudolf Maier, translated by Matteson EL. Mayo Foundation: Rochester, MN, 1996.
5. Cameron JS. Medical eponyms updated: Bright's disease. BJCP 1991; 45: 50-52.
6. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med 1948; 17: 175-205.
7. Wainwright J, Davson J. The renal appearances in the microscopic form of periarteritis nodosa. J Pathol Bacteriol 1950; LXII: 189-196.
8. Furlong TJ, Ibels LS, Eckstein RP. The clinical spectrum of necrotizing glomerulonephritis. Medicine 1987; 66: 192-201.
9. Serra A, Cameron JS, Turner DR, et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Metl 1984; 210: 181-207.
10. Bialastock D, Tange JD. Acute necrotising glomerulitis. Aust Ann Med 1959; 8: 282-289.
11. Glassock RJ, Cohen AH. Secondary glomerular diseases. In The Kidney, Brenner BM, Rector FC (eds). W. B. Saunders: Philadelphia 1981; 1498-1570.
12. Lindsay S, Aggeler PM, Lucia SP. Chronic granuloma associated with periarteruis nodosa. Am J Pathol 1944; 20: 1057-1071.
13. Pettersson EE, Sundelin B, Heigl Z. Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 1995; 43: 141-149.
14. Whitworth JA, Morel-Maroger L, Mignon F, Richet G. The significance of extracapillary proliferation. Nephron 1976; 16: 1-19.
15. Harrison DJ, Simpson R, Neary C, Wathen CG. Renal biopsy and antineutrophil antibodies in the diagnosis and assessment of Wegener's granuloma. Br J Dis Chest 1988; 82: 398-404.
16. Appel GB, Gee B, Kashgarian M, Hayslett JP. Wegener's granulomatosis - clinical pathologic correlations and long-term course. Am J Kidney Dis 1981; 1: 27-37.
17. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-1107.
18. Chanda JJ, Callen JP. Necrotizing vasculitis (angiitis) with granulomatosis. Int J Dermatol 1984; 23: 101-107.
19. Klinger H. Grenzformen der Periarteriitis nodosa. Frankfurt Z Pathol 1932; 42: 455-480.
20. Jennette JC, Falk RJ. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant 1998; 13 (Suppl 1): 16-20.
21. Jennette JC, Ewert BH, Falk RJ. Do antineutrophil cytoplasmic auloantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis? Rheum Dis Clin North America 1993; 19: 1-14.
22. Boudes P. Purely granulomatous Wegener's granulomatosis: a new concept for an old disease. Semin Arthritis Rheum 1990; 19: 365-370.
23. Takahashi H, Shibata Y, Fujita S, Okabe H. Immunohistochemical findings of arterial fibrinoid necrosis in major and lingual minor salivary glands of primary Sjögren's syndrome. Anal Cell Pathol 1996; 12: 145-157.
24. Heeringa P, Brouwer E, Klok PA, et al. Experimental antimyeloperoxidase associated necrotizing crescentic glomerulonephritis: the role of antibodies and complement. In Heeringa P. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis (PhD thesis). Grafisch Bedrijf Hellinga: Leewarden, 1997; 23-40.
25. Zeek PM. Periarteritis nodosa and other forms of necrotizing angiitis. N Engl J Med 1953; 248: 764-772.
26. Zeek PM. Periarterilis nodosa: a critical review. Am J Clin Pathol 1952; 22: 777-790.
27. Lie JT. Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum 1994; 37: 181-186.
28. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997; 337: 1512-1523.
29. Jennette JC, Charles LA, Falk RJ. Antineutrophil cytoplasmic autoantibodies: disease associations, molecular biology, and pathophysiology. Int Rev Exp Pathol 1991; 32: 193-221.
30. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-301.
31. Wegener F. Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystem und der Nieren. Beitr Pathol Anat 1939; 102: 36-68.
32. Godman GC, Churg J. Wegener's granulomatosis: pathology and review of the literature. Arch Pathol 1954; 58: 533-553.
33. Altshuler CH, Angevine DM. Histochemical studies on the pathogenesis of fibrinoid. Am J Pathol 1949; 25: 1061-1077.
34. Montgomery PO'B, Muirhead EE. A differentiation of certain types of fibrinoid and hyalin. Am J Pathol 1957; 33: 285-291.
35. Gitlin D, Craig JM, Janeway CA. Studies on the nature of fibrinoid in the collagen diseases. Am J Pathol 1957; 33: 55-77.
36. Bancroft JD, Stevens A, Theory and Practice, of Histological Techniques. Churchill Livingstone: Edinburgh, 1982; 131.
37. Bajema IM, Hagen EC, de Heer E, Bruijn JA. The PAF-Halmi staining distinguishes two types of glomerular fibrinoid necrosis in systemic vasculitis. JASN 1998; 9: 532A.
38. van der Woude FJ, Rasmussen N, Lobatto S, et al. Auto-antibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-429.
39. Falk RJ, Nachman PH, Jennette JC. What causes ANCA? Scientific Programme of ANCA and Vasculitis Symposium (Melbourne, Australia). 1997; 22-23.
40. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998; 53: 743-753.
41. Franssen CFM, Gans ROB, Arends B, et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int 1995; 47: 193-199.
42. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135: 921-930.
43. Geffriaudricouard C, Noël LH, Chauveau D, Houhou S, Grunfeld JP, Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993; 39: 125-136.
44. Bajema IM, Hagen EC, Hermans J, et al. Comparison of renal histopathology in patients with anti-PR3 and anti-MPO systemic vasculitis. JASN 1997; 8: 532A.